WHO ICTRP trial
Platform to Evaluate the Safety and Efficacy of post-exposure prophylaxis for…
JPRN-jRCTs031240115 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs031240115 |
|---|---|
| Public title | Platform to Evaluate the Safety and Efficacy of post-exposure prophylaxis for viral hemorrhagic fevers sub-protocol 01:Remdesivir for patients exposed to Ebora virus |
| Scientific title | Evaluation of Prophylaxis Safety and Efficacy in Post-Exposure Patients with viral hemorrhagic fevers: A Single-Site Platform sub-protocol 01:Remdesivir for patients exposed to Ebora virus |
| Primary sponsor | Morioka Shinichiro |
| Secondary sponsors | Ohmagari Norio;Health Labour Sciences Research Grant |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Prevention of the onset of Ebola virus and Ebola hemorrhagic fever in persons exposed to Ebola patie Ebora Virus |
| Interventions | First day of treatment Initial dose 150 mg once daily by intravenous infusion Dose Days 2 to 10 100 mg once daily by intravenous infusion |
| Registration date | May 27, 2024 |
| Target size | 5 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: